Capital International Investors Trims Position in Veeva Systems Inc. $VEEV

Capital International Investors cut its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 25.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 254,419 shares of the technology company’s stock after selling 86,832 shares during the period. Capital International Investors owned 0.16% of Veeva Systems worth $75,794,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. GPS Wealth Strategies Group LLC grew its stake in Veeva Systems by 196.4% during the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock valued at $25,000 after acquiring an additional 55 shares in the last quarter. Raiffeisen Bank International AG purchased a new stake in Veeva Systems in the 3rd quarter worth approximately $28,000. OLD Second National Bank of Aurora purchased a new stake in Veeva Systems in the 3rd quarter worth approximately $30,000. Cary Street Partners Investment Advisory LLC boosted its holdings in Veeva Systems by 58.3% in the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company’s stock valued at $38,000 after purchasing an additional 49 shares during the period. Finally, Elevation Point Wealth Partners LLC bought a new position in Veeva Systems in the 2nd quarter valued at $41,000. 88.20% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva acquired AI chat specialist Ostro for roughly $100M to add an AI-driven, compliant brand‑engagement chat tool for patients and HCPs — expands Commercial Cloud capabilities and product moat. Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
• Positive Sentiment: AOP Health standardized on Veeva’s Industry Cloud across R&D, quality, commercial and data — a notable customer win that supports recurring SaaS revenue and cross‑cloud adoption. AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas
• Positive Sentiment: Q4 results beat expectations with stronger demand for modernization (safety, R&D) and expansion among top 20 pharma customers; management emphasized scalable, automated core systems as the main growth driver. These fundamentals support revenue durability and the long‑term SaaS upsell story. 5 Revealing Analyst Questions From Veeva Systems’s Q4 Earnings Call
• Neutral Sentiment: Analyst/investor attention articles (Zacks, market commentary) highlight interest in Veeva but don’t add new material facts — they may increase trading volume but are unlikely alone to change fundamentals. Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
• Negative Sentiment: Citigroup lowered its expectations/price target for Veeva, signaling analyst concern that recent moves (acquisition spend, guidance cadence) or valuation may not justify current multiples — analyst downgrades can pressure the stock near term. Citigroup Has Lowered Expectations for Veeva Systems (NYSE:VEEV) Stock Price

Veeva Systems Trading Down 1.4%

Shares of NYSE VEEV opened at $186.96 on Thursday. The stock’s 50-day moving average is $201.48 and its 200 day moving average is $245.18. The stock has a market cap of $30.73 billion, a price-to-earnings ratio of 34.56, a P/E/G ratio of 1.31 and a beta of 1.09. Veeva Systems Inc. has a 1-year low of $168.13 and a 1-year high of $310.50.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. Veeva Systems had a return on equity of 14.11% and a net margin of 28.44%.The business had revenue of $835.95 million during the quarter, compared to analyst estimates of $810.95 million. During the same quarter in the prior year, the firm earned $1.74 earnings per share. Veeva Systems’s revenue for the quarter was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, analysts forecast that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Veeva Systems announced that its board has authorized a stock repurchase program on Monday, January 5th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the technology company to repurchase up to 5.5% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.

Insider Activity

In other news, insider Thomas D. Schwenger sold 1,000 shares of the company’s stock in a transaction on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total value of $231,430.00. Following the completion of the sale, the insider owned 23,204 shares of the company’s stock, valued at approximately $5,370,101.72. This represents a 4.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 10.30% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on VEEV. BTIG Research reaffirmed a “buy” rating and issued a $340.00 price target on shares of Veeva Systems in a report on Friday, November 21st. Jefferies Financial Group reissued a “buy” rating and set a $330.00 price objective on shares of Veeva Systems in a research note on Monday, November 24th. The Goldman Sachs Group started coverage on Veeva Systems in a research report on Tuesday, January 13th. They set a “sell” rating and a $215.00 target price for the company. Citigroup decreased their target price on Veeva Systems from $319.00 to $291.00 and set a “buy” rating on the stock in a research note on Monday. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Veeva Systems in a report on Friday, December 12th. Seventeen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $283.70.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.